1. Home
  2. SINT vs BNGO Comparison

SINT vs BNGO Comparison

Compare SINT & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SiNtx Technologies Inc.

SINT

SiNtx Technologies Inc.

HOLD

Current Price

$1.63

Market Cap

11.1M

Sector

Health Care

ML Signal

HOLD

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$1.20

Market Cap

12.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SINT
BNGO
Founded
1996
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
11.1M
12.5M
IPO Year
2007
2018

Fundamental Metrics

Financial Performance
Metric
SINT
BNGO
Price
$1.63
$1.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$11.00
$7.00
AVG Volume (30 Days)
46.2K
149.2K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
59.45
94.50
EPS
N/A
N/A
Revenue
$1,018,000.00
$12,000,735.00
Revenue This Year
$30.26
$14.99
Revenue Next Year
$413.20
$34.73
P/E Ratio
N/A
N/A
Revenue Growth
N/A
26.26
52 Week Low
$1.40
$1.00
52 Week High
$5.14
$5.50

Technical Indicators

Market Signals
Indicator
SINT
BNGO
Relative Strength Index (RSI) 46.12 56.61
Support Level $1.49 $1.07
Resistance Level $1.90 $1.35
Average True Range (ATR) 0.07 0.06
MACD 0.00 0.00
Stochastic Oscillator 34.78 67.86

Price Performance

Historical Comparison
SINT
BNGO

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Share on Social Networks: